NYSE:ANF

Abercrombie & Fitch (NYSE:ANF) Faces Downgrade Amidst Volatility

Font: Financial Modeling Prep  • Aug 18, 2026

Market Chart
  • Investment firm Raymond James downgraded Abercrombie & Fitch (NYSE:ANF) from "Outperform" to "Market Perform" at a stock price of $105.16.
  • Despite recent declines, Abercrombie & Fitch shares had a strong run, outperforming its retail sector, but now face an anticipated 18.10% decrease in earnings per share (EPS).
  • Investors await upcoming earnings report projections of $1.24 billion revenue and $1.90 EPS, while the broader analyst community maintains an average 'Buy' rating for Abercrombie & Fitch.

Abercrombie & Fitch is a global retailer specializing in apparel for teens and young adults. On August 18, 2026, the investment firm Raymond James issued a downgrade for the company. It adjusted its rating from "Outperform" to "Market Perform" when the stock price was $105.16, signaling a more neutral outlook on the stock's future performance.

This downgrade follows a period of notable stock movement. Abercrombie & Fitch's shares recently closed at $108.82, a 3.04% decrease, despite gains in the broader market. Prior to this, the stock had a strong run, gaining 15.48% and outperforming both its retail sector and the S&P 500, as highlighted by Zacks Investment Research.

Investors are now focused on the upcoming earnings report. Projections for the quarter anticipate revenue to increase 2.76% to $1.24 billion. However, earnings per share (EPS), which represents the company's profit per outstanding share of stock, is forecast to be $1.90, an 18.10% decrease from the previous year.

The downgrade from Raymond James presents a different view from the broader analyst community. Abercrombie & Fitch holds an average brokerage recommendation of 2.00, which is equivalent to a 'Buy' rating. As highlighted by Zacks Investment Research, this is based on opinions from 14 firms, with six issuing a 'Strong Buy' and two a 'Buy'.

The stock has shown significant volatility, trading between a 52-week high of $133.11 and a low of $65.45. The company currently has a market capitalization, or the total value of all its shares, of around $4.67 billion. This wide trading range reflects the changing sentiment surrounding the retailer's performance and outlook.

Market Overview
HOWL
Werewolf Therapeutics, Inc.
$0.89
105.38%
KNRX
Knorex Ltd.
$0.42
28.73%
GOSS
Gossamer Bio, Inc.
$0.16
1.02%
TSLL
Direxion Daily TSLA Bull 2X ETF
$9.89
11.40%
BITO
ProShares Bitcoin ETF
$10.42
6.17%
IBIT
iShares Bitcoin Trust ETF
$43.63
5.89%
MARA
Marathon Digital Holdings, Inc.
$11.15
0.00%
CAN
Canaan Inc.
$0.36
28.00%
LGCL
Lucas GC Limited Ordinary Shares
$0.06
-30.36%
INTC
Intel Corp.
$90.37
-1.91%